HAMILTON LANE ADVISORS LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
HAMILTON LANE ADVISORS LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q2 2021$251,000
-57.9%
11,861
-44.2%
0.08%
-59.8%
Q1 2021$596,000
-50.4%
21,253
-54.0%
0.19%
-56.7%
Q4 2020$1,201,000
-30.1%
46,1810.0%0.45%
-46.0%
Q3 2020$1,717,000
-27.6%
46,1810.0%0.83%
-34.6%
Q2 2020$2,370,000
+62.8%
46,1810.0%1.27%
+50.5%
Q1 2020$1,456,000
-53.8%
46,181
-12.6%
0.84%
-39.1%
Q4 2019$3,150,000
+62.6%
52,8260.0%1.38%
+70.7%
Q3 2019$1,937,000
-21.2%
52,8260.0%0.81%
-33.4%
Q2 2019$2,457,000
+15.8%
52,8260.0%1.22%
+8.5%
Q1 2019$2,121,000
+113.8%
52,826
+145.0%
1.12%
+29.8%
Q4 2018$992,000
+99100.0%
21,5620.0%0.86%
+112.5%
Q3 2018$1,0000.0%21,5620.0%0.41%
-55.2%
Q2 2018$1,000
-50.0%
21,562
-31.7%
0.91%
-42.7%
Q1 2018$2,000
-100.0%
31,562
-72.6%
1.59%
-59.5%
Q4 2017$7,594,000
+289.4%
115,344
+383.7%
3.92%
+433.0%
Q2 2015$1,950,000
+343.2%
23,847
+401.4%
0.74%
+266.2%
Q1 2015$440,0004,7560.20%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2019
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$22,344,00010.09%
Altium Capital Management LP 2,515,785$12,579,0003.47%
Deep Track Capital, LP 5,641,668$28,208,0001.99%
Paradigm Biocapital Advisors LP 839,257$4,196,0001.20%
SABBY MANAGEMENT, LLC 940,400$4,702,0000.68%
Monaco Asset Management SAM 500,000$2,500,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,000,000$25,000,0000.52%
CVI Holdings, LLC 1,460,595$7,303,0000.48%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$13,566,0000.38%
Rhenman & Partners Asset Management AB 1,000,000$4,960,0000.33%
View complete list of ESPERION THERAPEUTICS INC NE shareholders